We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bioseek | LSE:ATD | London | Ordinary Share | GB0009231639 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMATD
RNS Number : 6575R
Asterand PLC
08 November 2011
For Immediate Release 8 November 2011
Asterand plc
Asterand Receives Contract Extension From NCI
Asterand plc ("Asterand" or the "Company" - LSE: ATD) announces today that, further to the announcement on 23 September 2011, it has received notification from the National Cancer Institute ("NCI") that it will grant the Company a no cost contract extension to 30 September 2014 for The Cancer Genome Atlas contract ("TCGA"). This extension will allow Asterand to realise unexpended funds for the initial $5.4m contract beyond the original expiration date of 23 February 2012.
Contacts:
Asterand plc Jack Davis, Chairman and Interim Chief Tel: + 44 (0) 1763 211 600 / + Executive Officer 1 (313) 263-0960 Alan Fishman, Interim Chief Financial As above Officer Buchanan Communications Lisa Baderoon / Mark Court / Isabel Tel: +44 (0) 20 7466 5000 Podda Daniel Stewart & Company plc Antony Legge Tel: +44 (0) 20 7776 6550 Martin Lampshire
About Asterand
Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market. For more information about Asterand, go to www.asterand.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCZMMGMZNRGMZZ
1 Year Bioseek Chart |
1 Month Bioseek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
